ARDT ALERT: Hagens Berman Scrutinizing Suit Against Ardent Health (ARDT) Over Alleged Revenue Cycle Deception and $97M Adjustments
ARDT ALERT: Hagens Berman Scrutinizing Suit Against Ardent Health (ARDT) Over Alleged Revenue Cycle Deception and $97M Adjustments |
| [04-February-2026] |
ARDT Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Feb. 4, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing an updated notice to investors in Ardent Health, Inc. (NYSE: ARDT) regarding the March 9, 2026, lead plaintiff deadline in a pending securities class action the company and certain of its top executives. CLICK HERE TO SUBMIT YOUR ARDT LOSSES Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves. Despite allegedly assuring investors it used "detailed reviews of historical collections" to value its receivables, the company admitted in Nov. 2025 that it actually utilized a "180-day cliff" for reserves. This revelation, alongside a massive $54 million spike in professional liability reserves, triggered a 33% stock collapse. Visit Hagens Berman's ARDT Case Page: www.hbsslaw.com/cases/ardent-health View our latest video summary of the allegations: www.youtube.com/watch?v=ucqsF9PZIEA "We are investigating whether Ardent's purported active monitoring of receivables was a facade for a mechanical write-off system that ignored chronic payor denials," said Reed Kathrein, the Hagens Berman partner leading the firm's investigation of the pending alleged claims. ARDT Securities Class Action's Allegations: The Collectability Illusion The pending litigation alleges that Ardent Health and its executives issued misleading statements regarding the company's financial health:
Next Steps: Contact Partner Reed Kathrein Today Hagens Berman is a top-tier plaintiff litigation firm recognized for prosecuting complex securities class actions. Mr. Kathrein is actively advising investors who purchased ARDT shares between July 18, 2024 – Nov. 12, 2025. The Lead Plaintiff Deadline is March 9, 2026. TO SUBMIT YOUR ARDENT HEALTH (ARDT) LOSSES NOW, PLEASE USE THE SECURE FORM BELOW:
If you'd like more information and answers to frequently asked questions about the Ardent Health case and our investigation, read more » Whistleblowers: Persons with non-public information regarding Ardent Health should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email ARDT@hbsslaw.com. About Hagens Berman
SOURCE Hagens Berman Sobol Shapiro LLP | ||
Company Codes: NYSE:ARDT |













